Literature DB >> 16636185

The end of granulocyte colony-stimulating factor in acute myocardial infarction? Reaping the benefits beyond cytokine mobilization.

Jonathan M Hill, Jozef Bartunek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16636185     DOI: 10.1161/CIRCULATIONAHA.106.623777

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

Review 1.  Cellular therapies for heart disease: unveiling the ethical and public policy challenges.

Authors:  Amish N Raval; Timothy J Kamp; Linda F Hogle
Journal:  J Mol Cell Cardiol       Date:  2007-11-22       Impact factor: 5.000

Review 2.  Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond.

Authors:  Santosh K Sanganalmath; Ahmed Abdel-Latif; Roberto Bolli; Yu-Ting Xuan; Buddhadeb Dawn
Journal:  Basic Res Cardiol       Date:  2011-05-04       Impact factor: 17.165

Review 3.  Role of Stromal Cell-Derived Factor-1 in Endothelial Progenitor Cell-Mediated Vascular Repair and Regeneration.

Authors:  Ji-Hua Li; Yang Li; Dan Huang; Min Yao
Journal:  Tissue Eng Regen Med       Date:  2021-08-27       Impact factor: 4.451

Review 4.  Progenitor cell mobilization and recruitment: SDF-1, CXCR4, α4-integrin, and c-kit.

Authors:  Min Cheng; Gangjian Qin
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 5.  Therapeutic angiogenesis: controlled delivery of angiogenic factors.

Authors:  Hunghao Chu; Yadong Wang
Journal:  Ther Deliv       Date:  2012-06

Review 6.  Circulating endothelial progenitor cells: a new approach to anti-aging medicine?

Authors:  Nina A Mikirova; James A Jackson; Ron Hunninghake; Julian Kenyon; Kyle W H Chan; Cathy A Swindlehurst; Boris Minev; Amit N Patel; Michael P Murphy; Leonard Smith; Doru T Alexandrescu; Thomas E Ichim; Neil H Riordan
Journal:  J Transl Med       Date:  2009-12-15       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.